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In this study, we developed a technique for high-throughput screening (HTS) of skin penetration-enhancers using stratum corneum
lipid liposomes (SCLLs). A fluorescent marker, sodium fluorescein (FL), entrapped in SCLLs was prepared to provide a preliminary
evaluation of the effect of different concentrations of ethanol on the disruption effect of SCLLs, which is an alternative for
skin penetration-enhancing effects. In addition, SCLLs containing a fluorescent probe (DPH, TMA-DPH, or ANS) were also
prepared and utilized to investigate SCLL fluidity. The results using SCLL-based techniques were compared with conventional
skin permeation and skin impedance test using hairless rat skin. The obtained correlations were validated between FL leakage,
SCLL fluidity with various probes, or skin impedance and increases in the skin permeation enhancement ratio (ER) of caffeine as a
model penetrant. As a result, FL leakage and SCLL fluidity using ANS were considered to be good indices for the skin penetration-
enhancing effect, suggesting that the action of ethanol on the SC lipid and penetration-enhancing is mainly on the polar head
group of intercellular lipids. In addition, this screening method using SCLL could be utilized as an alternative HTS technique for
conventional animal tests. Simultaneously, the method was found to be time-saving and sensitive compared with a direct assay
using human and animal skins.
1. Introduction
Skin is of considerable interest as an administration route for
drugs with both local and systemic effects. However, themain
obstacle for drugs to pass through the skin and exert their
pharmacological activities is the intrinsic barrier function of
the stratum corneum (SC). The SC is the uppermost layer
of the skin which consists of keratin-filled corneocytes and
intercellular lipids [1, 2]. Generally, drugs in vehicles applied
topically onto the skin firstly distribute into the SC and
then diffuse mainly through the intercellular lipid domain
[3]. Because the intercellular lipids organize into multilamel-
lar complexes filling the intercellular spaces to provide a
strong barrier against the entry of the exogenous drugs [4],
approaches to overcome the skin barrier function have been
investigated extensively to improve the skin permeability of
drugs.
Use of chemical penetration enhancers (CPEs) is a con-
ventional and effective approach to overcome the high barrier
function of the SC. They promote the skin permeation of
drugs by reducing skin barrier resistance [5]. CPEs may
disrupt intercellular lipids or interact with intracellular pro-
teins or with both regions in the SC [6]. Conventional CPEs
have been screened using skin permeation experiments to
determine the cumulative amount of skin permeation, flux,
and permeability coefficient of drugs in the presence and
absence of CPEs [7]. However, these conventional approaches
are time-consuming, complicated, and resource-expensive.
These methods are not practical for high-throughput screen-
ing (HTS) with various types and concentrations of CPEs as
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part of their discovery and development. In addition, increas-
ing awareness of animal welfare issues nowadays has brought
about a reduction in animal-based experiments, especially in
the cosmetics industry. This situation gives rise to a need to
develop an effective replacement approach that can provide
HTS for effective CPEs and avoid the use of experimental
animals.
SC lipid liposomes (SCLLs) consist of a lipid mixture
similar to multilamellar lipid bilayers that are composed
of ceramides, cholesterol, cholesterol esters, and fatty acids
[4, 8]. SCLLs have been used as an SC intercellular lipid
mimicking model to investigate the effect of agents on the
skin permeability and the mechanism of enhanced skin
delivery [9, 10]. One of the determination procedures is based
on the change in transition temperature of SCLLs due to the
chemicals determined by DSC [9]. However, this technique is
also time-consuming and cannot simultaneously determine
various samples, and it is difficult to obtain quantitative data.
SCLLs containing entrappedmarker(s) (e.g., glucose, manni-
tol, and calcein) have been applied to determine the release
rate of the markers [9, 11–13]. In addition, labeled fluorescent
probes are also used to measure the fluidizing effect of CPEs
on SCLLs [14]. However, these methods are still not appro-
priate for HTS of CPEs because of the complicated analytical
methods and rather long experimental time.
Thus, the aim of the present study was to establish a
simple, quantitative, fast, and practical approach for HTS of
potential CPEs. Ethanol was used as a model CPE to firstly
investigate the potential of SCLLs based on the HTSmethod-
ology, because it iswell known and is already in use to increase
the skin penetration of various drugs such as hydrocorti-
sone, 5-fluorouracil, and estradiol [15–17]. SCLLs entrapping
a hydrophilic fluorescent probe, sodium fluorescein (FL),
and incubating with three fluorescent probes with different
lipophilicities were used to observe SCLL leakage and fluidity,
respectively, and compared with conventional in vitro skin
permeation tests as well as skin impedance test to determine
the effectiveness of this HTS technology.
2. Materials and Methods
2.1. Materials. FL, lignoceric acid, palmitic acid, boric acid,
potassiumchloride, sodiumhydroxide, chloroform,methanol,
and ethanol were purchased from Wako Pure Chemicals
Industries, Ltd. (Osaka, Japan). Cholesterol, cholesteryl sulfate,
octacosanoic acid, 1,6-diphenyl-1,3,5-hexatriene (DPH),N,N,
N-trimethyl-4-(6-phenyl-1,3,5-hexatrien-1-yl)phenyl-ammo-
nium p-toluenesulfonate (TMA-DPH), and 8-anilino-1-
naphthalenesulfonic acid ammonium salt (ANS) were from
Sigma-Aldrich (St. Louis, MO, USA). Ceramide type III
and ceramide type VI were from Evonik Industries AG
(Essen, Germany). These reagents were used without further
purification.
2.2. Experimental Animals. Male WBN/ILA-Ht hairless rats,
weighing between 200 and 260 g, were obtained from the Life
Science Research Center, Josai University (Saitama, Japan),
and Ishikawa Experimental Animal Laboratories (Saitama,
Japan). Rats were bred in a room maintained at 25 ± 2∘C, in
which the on and off times for the lighting were 07:00 and
19:00, respectively. Animals had free access to water and food
(MF, Oriental Yeast Co., Ltd., Tokyo, Japan).
All breeding procedures and experiments on the animals
were performed in accordance with the guidelines of the
Animal Experiment Committee of Josai University.
2.3. Methods
2.3.1. Preparation of Stratum Corneum Lipid Liposomes.
SCLLs were prepared by a thin film hydration method
reported by Hatfield and Fung [18] with a slight modification.
The SCLLs had 5.5mg/mL of total lipids including 33%
ceramide type III, 22% ceramide type VI, 25% cholesterol, 5%
cholesteryl sulfate, 7.5% lignoceric acid, 3.75% palmitic acid,
and 3.75% octacosanoic acid. FL was used as an entrapped
agent, and 0.1M borate buffer (pH 9.0) was used as a dispers-
ing medium. First, all lipid components were dissolved in the
mixture of chloroform :methanol (2 : 1) in a round-bottomed
flask.The solvent was then evaporated at 60∘C under reduced
pressure using a rotary evaporator until the thin film was
obtained on the flask wall.The flask was then purged with N2
gas and allowed to stand overnight. Next, the flask was placed
in a water bath at 90∘C for 30min for annealing of the thin
lipid film. Then, 2.5mg/mL FL in 0.1M borate buffer was
added to the flask and vortexed until the thin lipid film was
completely dissolved. An ultrasonic probe (VCX-750, Sonics
& Materials Inc., Newtown, CT, USA) was then immersed
in the liposome suspension at an amplitude of 20% for 30 s.
A freeze-thaw process was then performed by immersing
the flask in liquid N2 followed by a 90
∘C water bath, each
for 3min for 4 cycles. The obtained liposomes were further
extruded with a Lipex Extruder (Northern Lipids Inc.,
Burnaby, BC, Canada) using a membrane filter with pore
sizes of 400, 200, and 100 nm (Nuclepore track-etchedmem-
branes, GE Healthcare, Tokyo, Japan) (twice for each size of
membrane filter). After preparation of the liposomes, they
were centrifuged in an ultracentrifuge (Hitachi CS100GXL,
Hitachi Koki Co., Ltd., Tokyo, Japan) at 289,000×g, 4∘C twice
for 15min, twice for 10min, and 5 times for 5min. At each
centrifugation process, the supernatant was removed and the
same volume of 0.1M borate buffer was added and mixed
to prepare test liposome suspensions with removed free FL.
The blank SCLLs were also prepared by previously explained
process, without adding FL.
2.3.2. Determination of Sodium Fluorescein Leakage from
Stratum Corneum Lipid Liposomes. SCLLs containing FL
(FL-SCLLs) and different concentrations of ethanol (0–100%
ethanol in 0.1Mborate buffer) were placed at a ratio of 1 : 9 v/v
in an ultracentrifuge tube and mixed 5 times by pipetting.
The samples were allowed to stand for 30min and imme-
diately ultracentrifuged at 289,000×g, 4∘C for 5min. The
supernatant was collected to determine the FL content using
a microplate reader (SpectraMax M2e, Molecular Devices,
LLC., Sunnyvale, CA, USA) at excitation and emission wave-
lengths of 485 and 535 nm, respectively. This study was also
performed using 75% ethanol and 0.1M borate buffer to
represent the total and background FL leakage, respectively.
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The FL leakage from SCLLs was then calculated using the
following equation:
FL leakage (%) = (FLsample − FLbackground
FLtotal − FLbackground ) × 100. (1)
2.3.3. Measurement of Stratum Corneum Lipid Liposome
Membrane Fluidity. The fluorescent probes DPH, TMA-
DPH, and ANSwere solubilized in phosphate-buffered saline
(PBS) at concentrations of 2 × 10−5, 1 × 10−5, and 6 ×
10−3M, respectively. The fluidity of SCLL membranes was
determined by incubating blank SCLLs and each fluorescent
solution (25 : 75𝜇L) in a 96-well plate and then shaking using
an orbital shaker (IKA MS 1 Minishaker, Sigma-Aldrich,
Wilmington, NC, USA) at 500 rpm for 30min in the absence
of light. Next, different concentrations of ethanol in 0.1M
borate buffer (100 𝜇L) were added and shaken in the same
conditions. The fluorescence polarization (𝑃𝑓) was measured
at 25∘C using a microplate reader (SpectraMaxM5e, Molecu-
lar Devices, LLC., Sunnyvale, CA, USA).The respective exci-
tation and emissionwavelengths were 358 nm and 425 nm for
DPH, 365 nm and 430 nm for TMA-DPH, and 337 nm and
480 nm for ANS. 𝑃𝑓 value was calculated using the following
equation:
𝑃𝑓 = (𝐼0,0 − 𝐺𝐼0,90𝐼0,0 + 𝐺𝐼0,90) , (2)
where 𝐺 was the grating correction coefficient; 𝐺 =𝐼90,0/𝐼90,90. In addition, the decrease in 𝑃𝑓 indicating the
degree of membrane fluidity was calculated using the follow-
ing equation.
Decrease in 𝑃𝑓 = (𝑃𝑓,control − 𝑃𝑓,sample𝑃𝑓,control ) × 100, (3)
where 𝑃𝑓,control was obtained from blank SCLLs incubated
with fluorescent probe and 0.1M borate buffer.
2.3.4. Measurement of Skin Impedance Reduction Rate.
The mixture of three types of anesthesia (medetomi-
dine, 0.375mg/kg; butorphanol, 2.5mg/kg; and midazolam,
2mg/kg) was injected intraperitoneally into hairless rats.
Hairs were removed from the back under anesthesia. The
treated back skin was excised, and subcutaneous fat was
removed carefully using scissors.The skin was mounted with
the SC side up on a square-type diffusion cell with an effective
area of 19.5 cm2 and a receiver volume of 45mL. Eight donor
cells with an effective diffusion area of 0.795 cm2 were glued
with cyanoacrylate bond (Aron Alpha, Konishi Co. Ltd.,
Osaka, Japan) onto the skin. Then, 1.0 and 45mL of physio-
logical saline were added to the donor and receiver cells,
respectively, to hydrate the skin. Skin impedance was then
determined using an impedance meter (Asahi Techno Lab.,
Ltd., Kanagawa, Japan) 1 h after hydration. Thereafter, the
physiological saline was removed from the donor cell and
1.0mL of different concentrations of ethanol was applied for
1 h. At the end of the experiment, the donor solution was
removed, the same volume of fresh saline was added, and
skin impedance was determined again. The skin impedance
reduction (%) was calculated from the following equation.
Skin impedance reduction (%)
= (1 − Impedance after ethanol pretreatment
Impedance after hydration
)
× 100.
(4)
2.3.5. In Vitro Skin Permeation Experiments. Excised abdom-
inal skin from hairless rat was mounted in a vertical-type
Franz diffusion cell (receiver cell volume is 6.0mL and
effective permeation area is 1.77 cm2) with the SC side facing
the donor cells and the dermal side facing the receiver cell.
The receiver cell was filled with 6.0mL PBS (pH 7.4). PBS
was also added to the donor cells for 1 h for skin hydration.
Then, 0.5mL of 2mg/mL caffeine solution in 0, 10, 20, 30, 40,
50, 75, or 100% ethanol in PBS was applied to determine the
skin permeation of caffeine at 32∘Cover 8 h, while the receiver
solution was agitated at 500 rpm using a magnetic stirrer. At
predetermined times, 0.5mL aliquots were collected and the
same volume of PBS was added to keep the volume constant.
2.3.6. Determination of Caffeine Permeation. The concentra-
tion of caffeine was determined using a high-performance
liquid chromatography (HPLC) system (Prominence, Shi-
madzu Corporation, Kyoto, Japan) equipped with a UV
detector (SPD-M20A, Shimadzu Corporation). Briefly, the
receiving solutions were mixed with the same volume of
methanol. After centrifugation at 21,500×g at 4∘C for 5min,
the resulting supernatant (20𝜇L) was injected directly into
the HPLC system. Chromatographic separation was per-
formed at 40∘C using an Inertsil ODS-3, 5 𝜇m in diameter,
4.6mm I.D. × 150mm (GL Sciences Inc., Tokyo, Japan). The
mobile phase was 0.1% phosphoric acid :methanol 7 : 3 v/v
and the flow rate was 1.0mL/min. UV absorbance detection
was performed at 280 nm.
2.3.7. Calculation of Skin Permeation Parameter. Skin perme-
ation flux of 5 to 8 h after starting the experiment was cal-
culated by linear regression of the skin permeation profile of
caffeine. Skin permeation coefficient was obtained by divid-
ing the skin permeation flux with the initial concentration of
the applied caffeine in the donor compartment. The increase
in the skin-penetration-enhancement ratio (ER) after an
8 h permeation experiment was calculated with a following
equation.
Increase in ER = (𝑄sample − 𝑄control𝑄control ) , (5)
where 𝑄sample and 𝑄control are the cumulative amounts of
caffeine permeated per unit area of skin over 8 h from
different concentrations of ethanol and PBS, respectively.
2.3.8. Statistics. The differences among the obtained data
were analyzed using unpaired 𝑡-test. The differences were
considered significant when 𝑝 < 0.05. Pearson’s correlation
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Table 1: Flux, permeability coefficient, and enhancement ratio of caffeine from different concentrations of ethanol.
Formulation Flux (𝜇g/cm2/h) Permeability coefficient (×10−7 cm/s) Enhancement ratio
0% ethanol 0.81 ± 0.17 1.12 ± 0.24 1.00 ± 0.22
10% ethanol 0.88 ± 0.15 1.22 ± 0.21 1.07 ± 0.19
20% ethanol 1.52 ± 0.29 2.12 ± 0.40 1.60 ± 0.32
30% ethanol 1.95 ± 0.35 2.71 ± 0.49 2.02 ± 0.34
40% ethanol 2.94 ± 0.19 4.08 ± 0.26 2.82 ± 0.15
50% ethanol 3.82 ± 0.40 5.31 ± 0.55 4.33 ± 0.52
75% ethanol 3.67 ± 0.13 5.10 ± 0.19 4.85 ± 0.19
100% ethanol 4.22 ± 0.62 5.86 ± 0.86 4.26 ± 0.47
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Figure 1: Time course of cumulative amount of caffeine permeated
through full-thickness hairless rat skin after application with differ-
ent concentrations of ethanol. Each value represents the mean ± SE
(𝑛 = 3–5).
coefficient was used to determine the relationship between
the results from SCLL test and skin permeation study.
3. Results and Discussion
3.1. Results
3.1.1. Effect of Ethanol on In Vitro Skin Permeation of Caffeine.
In the present study, caffeine was selected as a hydrophilic
model drug to evaluate the relationship between its skin
permeation rate and the effect of different concentrations of
ethanol on SC lipid disruption. Figure 1 shows the cumulative
amounts of caffeine permeated through the excised hairless
rat skin. Typical in vitro skin permeation profiles of caffeine
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Figure 2: Effect of ethanol concentration on the increase in the skin-
penetration-enhancement ratio (ER) of caffeine permeated over 8 h.
Each value represents the mean ± SE (𝑛 = 3–5).
(lag time and following almost steady-state profiles) were
observed in all cases when using 0–100% ethanol as in the
donor solution. Figure 2 illustrates the relationship between
the increase in ER and the ethanol concentration in the donor
solution. Figures 1 and 2 show that the skin permeation of
caffeine was strongly dependent on the ethanol concentration
in the caffeine solution. When the ethanol concentration
increased from 0% to 50%, the skin permeation rate of
caffeine also increased. However, at 100% ethanol, caffeine
permeation was rather decreased compared with the samples
with 50% and 75% ethanol. The maximum skin permeation
of caffeine was observed with 75% ethanol in the present
study. The skin permeation flux, permeability coefficient,
and enhancement ratio of caffeine obtained from different
concentrations of ethanol are also summarized in Table 1.
3.1.2. Effect of Ethanol on the Skin Impedance. Skin impe-
dance has been used as an index of the skin permeation rate of
drugs, especially of hydrophilic drugs, because the decrease
in skin impedance is related to decreased barrier function
of the skin. Therefore, we determined skin impedance after
Journal of Pharmaceutics 5
Table 2: Characteristics of blank stratum corneum lipid liposomes
(SCLLs) and sodium fluorescein entrapped in SCLLs (FL-SCLLs).
Blank SCLLs FL-SCLLs
Size (nm) 221.1 ± 8.6 282.8 ± 3.2
Polydispersity index 0.556 ± 0.017 0.215 ± 0.014
Zeta potential (mV) −87.0 ± 2.3 −99.6 ± 3.3
0
20
40
60
80
100
Sk
in
 im
pe
da
nc
e r
ed
uc
tio
n 
(%
)
20 40 60 80 1000
Concentration of ethanol (% v/v) 
Figure 3: Effect of different concentrations of ethanol on the
percentage of skin impedance reduction. Each value represents the
mean ± SE (𝑛 = 3–5).
pretreatment with different concentrations of ethanol. Fig-
ure 3 shows the decrease in skin impedance with different
concentrations of ethanol on excised back skin of hairless
rats. Ethanol treatment changed the skin impedance even at a
low concentration. Ethanol solution at a concentration of 5%
reduced skin impedance by about 30%, and 20–100% ethanol
could reduce skin impedance about 75–80%.
3.1.3. Stratum Corneum Lipid Liposomes Characteristics.
Table 2 summarizes the characteristics of blank SCLLs and
FL-SCLLs prepared in the present study. The vesicle size and
distribution of FL-SCLLs were a little larger but narrower,
respectively, than the blank SCLLs, indicating that the vesicle
dispersion was homogeneous. Both the liposome formula-
tions showed highly negative surface charge of−87.0± 2.3 and−99.6 ± 3.3mV, respectively, because of the ionized fraction
of fatty acids at pH 9.0. The presence of FL anions inside
the SCLLs leads to higher negative surface charge. The zeta
potential of both SCLL formulations indicated high elec-
trostatic repulsion among the particles and excellent kinetic
stability [19].
3.1.4. Effect of Ethanol on the Sodium Fluorescein Leakage
from Stratum Corneum Lipid Liposomes. Next, the effect
of different concentrations of ethanol was tested on the
disruption of SCLLs. Figure 4 shows the relation between the
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Figure 4: Effect of different concentrations of ethanol on the sodium
fluorescein (FL) leakage from stratum corneum lipid liposomes
(SCLLs). Each value represents the mean ± SE (𝑛 = 3).
FL leakage (%) and ethanol concentration. As the ethanol
concentration increased, FL leakage also increased in a
concentration-dependent manner. At low ethanol concentra-
tions (0–5% ethanol), no significant promotion was observed
in FL leakage comparedwith the control (0.1Mborate buffer).
At higher concentrations of ethanol, on the other hand,
FL leakage increased proportionally with the concentration.
However, nomore FL leakage was observed atmore than 50%
ethanol.
3.1.5. Effect of Ethanol on Membrane Fluidity of Stratum
Corneum Lipid Liposomes. Figure 5 shows the membrane
fluidity of blank SCLLs incubated with fluorescent probes
with different lipophilicities. The decrease in 𝑃𝑓 was used
as an index of membrane fluidity of SCLLs. The results
with DPH and TMA-DPH as fluorescent probes showed
relatively lowmembrane fluidity.Themaximumdecrease was
observed at 100% ethanol, which provided 37.8% and 17.9%
decreases in 𝑃𝑓 for DPH and TMA-DPH, respectively. High
membrane fluidity was observed when using ANS probe at
low concentrations of ethanol.
3.1.6. Relationship between Sodium Fluorescein Leakage
and Increase in Skin-Penetration-Enhancement Ratio. SCLLs
were used as an SC lipid model to investigate the enhancing
effect of ethanol on the skin permeation of caffeine. The cor-
relation was evaluated between the present SCLL-based HTS
data and the conventional skin-penetration-enhancing pro-
files of caffeine. Figure 6(a) shows the relationship between
the increase in ER of the cumulative amount of caffeine
permeated through skin over 8 h (𝑥-axis) and FL leakage
(%) from SCLLs (𝑦-axis). The correlation coefficient of this
relationship was 0.888. The obtained profile was concave
relative to 𝑥-axis, indicating that ethanol more markedly
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Figure 5: Effect of different concentrations of ethanol on the
percentage decrease in fluorescence polarization (𝑃𝑓) using three
fluorescent probes: 1,6-diphenyl-1,3,5-hexatriene (DPH), N,N,N-
trimethyl-4-(6-phenyl-1,3,5-hexatrien-1-yl)phenyl-ammonium p-
toluenesulfonate (TMA-DPH), and 8-anilino-1-naphthalenesulfonic
acid ammonium salt (ANS). Each value represents the mean ± SE
(𝑛 = 3).
affected SCLL disruption than the skin permeation of caf-
feine, especially at low concentrations of ethanol. Almost lin-
ear relationship could be observed at higher concentrations
of ethanol. The semilog plot, as shown in Figure 6(b), shows
a very high correlation coefficient of 0.974.
3.1.7. Relationship between Stratum Corneum Lipid Liposome
Membrane Fluidity and Increase in Skin Penetration-
Enhancement Ratio. Figure 7(a) shows a relationship
between SCLL membrane fluidity and the increase in the
ER. The data from 100% ethanol were not included in this
correlation, because the reduction in the ER might be an
exceptional case, with such a high concentration of ethanol
having a reversed effect on the skin permeation of caffeine.
The linear relationship could be obtained in SCLLmembrane
fluidity measured using the ANS probe with a correlation
coefficient of 0.899, whereas DPH and TMA-DPH showed
poorer correlations (𝑅2 of DPH and TMA-DPH: 0.638
and 0.748, resp.). In the data using ANS probe, a higher
correlation was obtained in the semilog plot as shown in
Figure 7(b), similar to Figure 6(b).
3.1.8. Relationship between Skin Impedance Reduction and
Increase in Skin Penetration-Enhancement Ratio. Figure 8
shows a relation between skin impedance reduction and
increase in ER. No good relationships were observed; the
correlation coefficientwas 0.456 between the increase in ER at
8 h and impedance reduction, although such skin impedance
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Figure 6:The relationship between sodium fluorescein (FL) leakage
and increase in the skin penetration-enhancement ratio (ER) (a);
log ER of caffeine permeated over 8 h from each concentration of
ethanol solution (b). Each value represents the mean ± SE (𝑛 = 3–5).
was reported to be correlated with a big amount of skin
permeation data of drugs.
3.2. Discussion. In the present study, an HTS approach
for searching for effective CPEs was established based on
using SCLLs as a model membrane mimicking the primary
skin-penetration domain of the SC lipid bilayer. Different
concentrations of ethanol were used in the first step, because
this is a well-known CPE contained in many topical and
transdermal formulations. The composition of lipids used in
SCLLs, closely similar to the lipid composition of intercellular
Journal of Pharmaceutics 7
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Figure 7: The relationship between percentage of decrease in fluorescence polarization (𝑃𝑓) using various fluorescent probes and increase
in the skin penetration-enhancement ratio (ER) (a); log ER of caffeine permeated over 8 h from each concentration of ethanol solution (b).
Each value represents the mean ± SE (𝑛 = 3–5). The data from 100% ethanol was excluded in this figure.
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Figure 8: The relationship between skin impedance reduction and increase in the skin penetration-enhancement ratio (ER) (a); log ER of
caffeine permeated over 8 h from each concentration of ethanol solution (b). Each value represents the mean ± SE (𝑛 = 3–5).
lipids, was comprised of 33% ceramide type III, 22% ceramide
type IV, 15% fatty acids (palmitic : lignoceric : octacosanoic
acid: 1 : 2 : 1), 25% cholesterol, and 5% cholesteryl sulfate and
buffer (pH, 9.0), which was reported to enhance the stability
of SCLL vesicles [18]. A fluorescent hydrophilic marker, FL,
was entrapped in SCLLs in order to monitor the degree
of its membrane rupture by ethanol. Furthermore, SCLL
membrane fluidity using probe of various lipophilicities was
also measured in an HTS manner. These experiments were
compared with conventional methods for the determination
of skin penetration-enhancing effect of chemicals: in vitro
permeation and impedance studies using hairless rat skin.
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Skin permeation experimentswith caffeinewere conduct-
ed in asymmetric conditions to determine the penetration-
enhancing effect of ethanol. The increase in ER by ethanol
was concentration-dependent (Figures 1 and 2). A similar
ethanol concentration-dependent effect was observed when
using indomethacin in our previous study [20]. However, the
permeation of caffeine decreased at the highest ethanol con-
centration, because highly concentrated ethanol dehydrates
the skinmembrane and reduces the skin permeation of drugs
[21]. Our previous study also found that the skin permeability
of hydrophilic drugs was increased but inversely decreased
by low and high concentration of ethanol, respectively [22].
In addition, X-ray diffraction data confirmed that low con-
centrations of ethanol disturbed the short lamellar structure
of SC lipids, but the high concentration caused an aligned
structure [23].
Skin impedance has been reported to correlate with drug
permeability through skin [22, 24]. Then, we determined the
back skin impedance to increase the sensitivity of ethanol
on impedance and to reduce the number of rats sacrificed.
Ethanol could reduce the skin impedance and clearly alter
the flux of low molecular weight ions through the skin [22].
Nevertheless, the relationship was not linear between the
reduction in skin impedance and the increase in ER (Fig-
ure 8). This is because low concentrations of ethanol could
greatly reduce the skin impedance but higher concentrations
remained stable (Figure 3). Therefore, the reduction in skin
impedance by ethanol might not be a good indicator for the
skin penetration-enhancement effect. This may be because
of different thermodynamic activities of caffeine in different
concentrations of ethanol when using the same concentration
of caffeine in different ethanol concentrations. In otherwords,
the thermodynamic activity of a certain concentration of
caffeine is low in high concentrations of ethanol, resulting in
lower skin permeation of caffeine fromhigher concentrations
of ethanol solution. Another possibility is that lower skin
impedance may be obtained from the same concentra-
tion of caffeine at low ethanol concentrations because skin
impedance is also dependent on the ethanol concentration in
skin. When checking other CPEs rather than solvent types
such as ethanol, skin impedance may be dependent on the
penetration-enhancing effect, because little contribution is
expected by nonsolvent type enhancers on the thermody-
namic activity of penetrants.
Using SCLL leakage tests, FL leakage was observed from
low (≥5%) to high (∼100%) concentrations of ethanol and
the degree was ethanol concentration-dependent (Figure 4),
suggesting that the disruption effect on the SCLL membrane
was closely related to ethanol concentration. Ethanol has been
reported as a markedly effective skin penetration-enhancer
by various mechanisms because of an increase in drug solu-
bility, improvement in drug partitioning into the SC, modifi-
cation of thermodynamic activity of drugs, solvent (ethanol)
drag effect across the skin, fluidization and extraction of SC
lipids, and the structure modification of SC keratin [21, 25].
SCLLs used in the present experiment are a model represent-
ing only the SC lipids with lack of cellular proteins such as
keratin [6].Therefore, the present SCLL leakage results might
DPH
TMA-DPH
ANS
FL
Figure 9: Location of fluorescent probes in stratum corneum lipid
liposomes (SCLLs).
not be totally predictive for all mechanisms associated with
the skin penetration-enhancing effects of ethanol.
SCLLs mimic SC lipids in the intercellular domain where
CPEs act. Then, three different fluorescent probes, DPH,
TMA-DPH, and ANS, were used to determine the SCLL
membrane fluidity in order to better understand the effect of
ethanol on lipid packing.High fluidity in the SCLLmembrane
represents a high degree of lipid molecule disorganization,
which provides high permeability of drugs through the
bilayer [26]. The ethanol effect on the fluidity of SCLL was
determined, especially in the region where each fluorescent
probe was contained, as depicted in Figure 9. DPH and
TMA-DPH serve as markers for molecular movement in
the hydrophobic core and superficial surface of SCLLs [27],
respectively.The effect of ethanol on SCLL fluidity usingDPH
and TMA-DPH showed similar patterns (Figure 5). Although
lower ethanol concentrations could not promote SCLL fluid-
ity, the effect was clearly found with more than 50% ethanol.
On the other hand, ANS, a marker of molecular movement
on the exterior membrane surface [27], changed membrane
fluidity even at low ethanol concentrations, and good linearity
was observed between SCLL fluidity and ethanol concen-
tration (Figure 5). The results using these three fluorescent
probes provided a possible effect of ethanol on SCLL mem-
branes, suggesting that ethanol disrupted mainly the polar
head region outside the liposome membrane similar to a
previous report [28].The use of ANSmay be themost suitable
for evaluating the skin penetration-enhancement effects from
ethanol.
Good correlations were obtained especially in the FL
leakage test (Figure 6) and SCLL fluidity detected using the
ANS probe (Figure 7), indicating that SCLLs could be an
optionalmodel to investigate the skin penetration-enhancing
effects of CPEs as well as their mode of actions. Furthermore,
our approach was able to determine the enhancing effect by
ethanol in a very short period. Thus, time-consuming skin
permeation experiments, which normally take about 8 h to
a few days, could be markedly reduced to only 30–60min
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incubation times using SCLLs with probes andCPEs. Various
samples could be simply and simultaneously evaluated using
a 96-well plate fluorescence spectroscopy microplate reader.
In addition, our method could avoid the use of animal
membranes in comparison with typical skin permeation
approaches. Despite the observation that this method was
quite sensitive even at low concentrations of ethanol, which
vary from the actual results of skin permeation experiments,
this approach could be a practical tool to discover effective
CPEs for use in topical and transdermal formulations.
4. Conclusions
Thepresent HTS approach using SCLLs could be a promising
model to determine the effect of ethanol on the skin per-
meability of drugs, because a good correlation was obtained
from SCLL-based experiments and a skin permeation study.
The ease of handling of the various fluorescent probes could
also identify the possible mechanism of action of ethanol for
enhancing skin permeation. Although skin impedance tests
have been reported to correlate with skin permeability, SCLL
results showed better predictability for the skin penetration-
enhancement effect by ethanol, for which the primary action
is on the disruption of SC intercellular lipids. The present
findings could clarify the advantages of SCLLs not only for
screening approaches to investigate the potential of CPEs but
also for drug delivery systems.
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